NCT06450613View on ClinicalTrials.gov

Cost-effectiveness of RFA vs. PEI for Early-stage HCC

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

October 31, 2020

Study Completion Date

March 31, 2021

Conditions
Cost EffectivenessExposure to Radiofrequency
Interventions
DEVICE

radiofrequency ablation

HCC Radiofrequency ablation

OTHER

percutaneous ethanol injection

HCC percutaneous ethanol injection

Trial Locations (1)

05652900

Hospital Israelita Albert Einstein, São Paulo

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER

NCT06450613 - Cost-effectiveness of RFA vs. PEI for Early-stage HCC | Biotech Hunter | Biotech Hunter